Theratechnologies Files 6-K Report
| Field | Detail |
|---|---|
| Company | Theratechnologies Inc. |
| Form Type | 6-K |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulatory-filing, press-release
TL;DR
Theratechnologies filed a 6-K, likely with a press release attached. No major news in the filing itself.
AI Summary
Theratechnologies Inc. filed a Form 6-K on April 9, 2025, to report a press release dated April 9, 2025. The filing does not contain specific financial figures or operational updates in the provided text, but it indicates the company is a foreign private issuer based in Montreal, Canada, and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing serves as a notification to the SEC and investors about important company information, typically a press release, which could contain material updates.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a press release and does not contain specific financial or operational risks.
Key Players & Entities
- Theratechnologies Inc. (company) — Filer of the report
- Jocelyn Lafond (person) — General Counsel and Corporate Secretary signing the report
- April 9, 2025 (date) — Date of the report and press release
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report a press release dated April 9, 2025, as required for foreign private issuers.
Where is Theratechnologies Inc. based?
Theratechnologies Inc. is based in Montreal, Quebec, Canada.
What is the SIC code for Theratechnologies Inc.?
The Standard Industrial Classification (SIC) code for Theratechnologies Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Who signed the Form 6-K on behalf of Theratechnologies Inc.?
Jocelyn Lafond, General Counsel and Corporate Secretary, signed the Form 6-K on behalf of Theratechnologies Inc.
Does this filing include an annual report?
No, this filing indicates that the registrant files annual reports under cover of Form 20-F, not this 6-K form.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 9, 2025 by Jocelyn Lafond regarding Theratechnologies Inc..